At the beginning of June, Nanolek experienced staff changes at the level of top management: Vladimir Khristenko stepped in as new President of the Company. The CEO’s position is still held by Mikhail Nekrasov.

Before getting involved in the pharmaceutical industry, Vladimir Khristenko was employed at the Chelyabinsk Pipe Rolling Plant (CPRP), where he worked his way upward from the project manager until he became Director of Group’s Service Division and Chairman of the Board of CPRP-KTS. Vladimir Khristenko joined the Nanolek team as investor in early 2013. Together with the owner of Epidbiomed Group Mikhail Nekrasov he controls 50.01% of company’s shares, RUSNANO holds 49.99% of the shares in the project.

“I lost interest in watching the company’s growth from one report to another, that is why I’m in the team now,” said Vladimir Khristenko while commenting on his appointment. Currently, at Nanolek he is responsible for the strategic development of the company, portfolio construction and cooperation with partners.